HEALTH

Heart Disease Treatment and Management: Medications, Procedures, Rehabilitation, and Long-Term Care

Heart disease is not a single diagnosis. It includes coronary artery disease, heart failure, abnormal heart rhythms, valve disorders, cardiomyopathy, congenital conditions, and other problems affecting the heart’s structure or function.

By Dr. Elena Park·Jul 23, 2026 · 76 min read

Key Takeaways

•Heart-disease treatment depends on the exact diagnosis, severity, symptoms, and individual risks.

•Management often combines lifestyle measures, medication, procedures, rehabilitation, and long-term monitoring.

•Medicines should not be started, stopped, or adjusted without professional guidance.

•A stent, operation, or implanted device may correct a specific problem without removing the need for continuing care.

•Cardiac rehabilitation is an evidence-based part of recovery for many people after cardiac events and procedures.

•Monitoring symptoms, medication effects, blood pressure, laboratory results, and functional ability helps clinicians assess whether treatment is working.

•New or severe chest discomfort, sudden breathlessness, fainting, or collapse requires immediate emergency action.

Treatment therefore varies widely. One person may need lifestyle changes and cholesterol-lowering medication, while another may require anticoagulation, catheter ablation, valve replacement, coronary bypass surgery, or an implanted cardiac device.

Modern heart care usually combines several goals:

•relieving symptoms;

•slowing disease progression;

•preventing heart attack, stroke, or cardiac arrest;

•controlling contributing conditions;

•improving physical function and quality of life;

•reducing hospitalization risk;

•supporting safe long-term self-management.

TheNational Heart, Lung, and Blood Institutedescribes heart treatment as a combination of medicines, procedures, implanted devices, rehabilitation, and ongoing care. The appropriate combination depends on the diagnosis, disease severity, symptoms, other medical conditions, and individual treatment goals.

This article provides a general medical overview. It is not a replacement for diagnosis, emergency care, or an individualized treatment plan from a qualified healthcare professional.

Understanding Heart Disease Treatment

The first step in treatment is identifying which heart condition is present and how seriously it is affecting the body.

Evaluation may include:

•a medical and family history;

•blood pressure and pulse measurement;

•blood tests;

•an electrocardiogram;

•an echocardiogram;

•exercise or stress testing;

•ambulatory heart-rhythm monitoring;

•coronary CT or angiography;

•cardiac MRI;

•other imaging or functional tests.

TheNHLBI’s overview of heart testsexplains that different tests examine the heart’s electrical activity, blood flow, valves, chambers, muscle, and blood vessels. No single test is suitable for every patient or every suspected condition.

Treatment plans are generally based on four questions:

1.What is causing the condition?

2.How advanced is it?

3.Which complications are most likely?

4.Which treatment offers the best balance of benefit and risk?

A procedure that is appropriate for an acute heart attack may not be necessary for stable coronary disease. Similarly, a medication used for heart failure may not be suitable for every type of heart failure or for someone with certain kidney, blood-pressure, or rhythm problems.

The Main Components of Heart Disease Management

Treatment area Examples Main purpose

Lifestyle and risk-factor management Nutrition, activity, tobacco cessation, sleep, weight and stress management Reduce cardiovascular strain and future risk

Medication Cholesterol, blood-pressure, anti-clotting, rhythm and heart-failure medicines Control symptoms, prevent complications, or slow disease

Procedures Angioplasty, stenting, ablation, cardioversion and valve procedures Restore blood flow, rhythm, or normal heart function

Surgery Coronary bypass, valve repair or replacement, congenital repair Correct structural or blood-flow problems

Implanted devices Pacemaker, ICD, cardiac resynchronization device, ventricular assist device Support rhythm, pumping ability, or protection from dangerous arrhythmias

Cardiac rehabilitation Supervised exercise, education and risk-factor support Improve recovery, confidence, function and long-term health

Monitoring and follow-up Examinations, blood tests, imaging, symptom tracking Measure response and detect complications

These components are not alternatives in every case. Many people need several of them at the same time.

Lifestyle and Risk-Factor Management

Lifestyle changes remain important even when medication or surgery is required. They can support treatment, reduce additional cardiovascular risk, and improve the management of high blood pressure, cholesterol, diabetes, and excess weight.

They should not, however, be presented as a guaranteed cure or a substitute for indicated medical therapy.

Heart-healthy eating

Current cardiovascular guidance emphasizes an overall eating pattern rather than a single “heart superfood.”

A heart-supportive pattern generally includes:

•vegetables and fruits;

•whole grains;

•legumes;

•nuts and seeds;

•fish and other suitable sources of protein;

•minimally processed foods;

•unsaturated rather than trans fats;

•limited added sugar, excessive sodium, and heavily processed meats.

The American Heart Association’sdiet and lifestyle recommendationsstate that healthy eating should be considered part of both preventing and managing cardiovascular disease. Its2026 dietary guidancealso emphasizes flexible food-based patterns rather than one mandatory diet.

Dietary needs may differ for people with heart failure, kidney disease, diabetes, anticoagulant use, swallowing problems, or unintended weight loss. Restrictive diets should not be started without appropriate professional advice.

Physical activity

Regular physical activity may improve cardiovascular fitness, blood-pressure control, metabolic health, mobility, and quality of life.

The appropriate type and intensity depend on the condition. Someone with stable cardiovascular disease may be encouraged to exercise regularly, while a person with uncontrolled symptoms, recent surgery, severe valve disease, or a dangerous arrhythmia may need assessment and supervised progression.

TheNHLBInotes that physical activity can support heart health and reduce the risk of several chronic diseases. For people recovering from a cardiac event, supervised cardiac rehabilitation may provide a safer starting point than independent intensive exercise.

Tobacco and nicotine

Stopping smoking is one of the most important modifiable steps for people with coronary and vascular disease.

Tobacco smoke damages blood vessels, promotes inflammation and clot formation, reduces oxygen delivery, and raises the risk of heart attack and stroke. Benefits can occur even after many years of smoking.

Quitting can be difficult, and support may include counseling, structured cessation programs, nicotine-replacement therapy, or prescription medicines. The correct approach depends on medical history and local availability.

Blood pressure, cholesterol, and diabetes

High blood pressure, elevated LDL cholesterol, and diabetes can accelerate cardiovascular damage without causing noticeable symptoms.

Management may involve lifestyle changes, medication, or both. The2025 AHA/ACC high blood pressure guidelineuses cardiovascular risk and individual clinical circumstances to guide treatment decisions rather than treating every patient identically.

Targets for blood pressure, cholesterol, and blood glucose should be determined with a healthcare professional. They may differ according to age, previous heart attack or stroke, kidney function, diabetes, frailty, pregnancy, and medication tolerance.

Medications Used in Heart Disease

Cardiovascular treatment often involves more than one medicine because different drugs address different mechanisms.

Cholesterol-lowering medicines

Statins are widely used to lower LDL cholesterol and reduce the risk of cardiovascular events in people with established atherosclerotic disease or sufficiently high risk.

Other lipid-lowering medicines may be added when statins do not produce an adequate response, are not tolerated, or when inherited cholesterol disorders are present.

Medication decisions should consider overall cardiovascular risk rather than one laboratory value alone.

Antiplatelet medicines

Antiplatelet drugs reduce the ability of platelets to form clots.

They may be prescribed after a heart attack, acute coronary syndrome, angioplasty, or coronary stent. The2025 ACC/AHA acute coronary syndromes guidelineprovides updated recommendations on anti-clotting treatment and invasive care following acute coronary events.

Aspirin should not be started routinely without medical guidance. Its potential cardiovascular benefit must be weighed against bleeding risk.

Anticoagulants

Anticoagulants act on the blood-clotting system rather than directly on platelets.

They are commonly used for selected people with atrial fibrillation, artificial heart valves, blood clots, or other conditions associated with embolic risk.

These medicines can prevent serious strokes but may also cause significant bleeding. Dose selection, kidney function, interactions, and procedure planning require professional monitoring.

Blood-pressure and heart-protection medicines

Several medication groups may lower blood pressure or reduce strain on the heart, including:

•ACE inhibitors;

•angiotensin receptor blockers;

•calcium-channel blockers;

•beta blockers;

•diuretics;

•mineralocorticoid receptor antagonists;

•other vasodilating medicines.

The correct choice depends on the condition being treated. A medicine that is beneficial after a heart attack or in one form of heart failure may be unsuitable for a patient with very low blood pressure, a slow heart rate, pregnancy, certain kidney conditions, or another contraindication.

Heart-failure medicines

Heart-failure treatment depends partly on whether the heart’s ejection fraction is reduced, mildly reduced, or preserved.

Depending on the diagnosis, treatment may include combinations of:

•an angiotensin receptor–neprilysin inhibitor, ACE inhibitor, or ARB;

•an evidence-based beta blocker;

•a mineralocorticoid receptor antagonist;

•an SGLT2 inhibitor;

•diuretics for fluid congestion;

•additional medicines for selected symptoms or risk factors.

TheNHLBI heart-failure treatment overviewstresses that treatment may combine lifestyle changes, medicines, devices, and procedures. Some drugs improve long-term outcomes, while others mainly control fluid buildup or symptoms.

Rhythm-control and rate-control medicines

Arrhythmia medicines may:

•slow a rapid heartbeat;

•maintain a normal rhythm;

•restore a normal rhythm;

•reduce the risk of blood clots;

•treat an underlying trigger.

Antiarrhythmic medicines can sometimes cause or worsen abnormal rhythms. They often require electrocardiograms, laboratory monitoring, or specialist supervision.

TheNHLBI arrhythmia treatment guideexplains that treatment may include medication, procedures, and implanted devices depending on the rhythm and its effects.

Medication Safety and Adherence

Cardiovascular treatment can become complicated when several medicines are prescribed.

Patients should maintain an updated list containing:

•medicine names;

•doses;

•timing;

•reason for use;

•prescribing clinician;

•allergies or previous adverse reactions;

•over-the-counter products and supplements.

The American Heart Association’smedication management guidanceadvises discussing non-prescription medicines and supplements with a healthcare professional because they may affect blood pressure, bleeding risk, kidney function, or prescribed drugs.

A medication should not usually be stopped, doubled, or restarted without instructions. Sudden discontinuation of certain heart medicines can create serious risks.

Side effects, affordability, confusing schedules, swallowing difficulties, and forgetfulness should be discussed openly. These problems may sometimes be addressed by adjusting the treatment plan rather than abandoning therapy.

Procedures and Surgery

Angioplasty and coronary stenting

Percutaneous coronary intervention uses a catheter to open a narrowed or blocked coronary artery. A stent may be placed to help keep the artery open.

It is often used urgently during certain heart attacks. In stable coronary disease, the decision depends on symptoms, anatomy, response to medication, and the expected benefits and risks.

A stent treats a specific narrowing but does not remove the underlying tendency to develop atherosclerosis. Medication, risk-factor management, and follow-up remain necessary.

Coronary artery bypass surgery

Coronary artery bypass grafting creates a new route for blood to travel around severely narrowed or blocked arteries.

It may be considered for complex or extensive coronary disease, certain high-risk anatomical patterns, or symptoms that are not adequately controlled by other treatment.

Recovery normally includes wound care, medication, gradual return to activity, and often cardiac rehabilitation.

Valve repair and replacement

Heart valves may become narrowed or may leak.

Treatment ranges from regular monitoring to surgical or catheter-based repair or replacement. The choice depends on:

•which valve is affected;

•the severity of narrowing or leakage;

•symptoms;

•heart function;

•age and general health;

•procedural risk;

•whether other heart surgery is needed.

TheNHLBIdescribes both surgical and transcatheter options, including transcatheter aortic valve replacement for suitable patients.

Cardioversion and catheter ablation

Cardioversion attempts to restore a normal rhythm using medication or a controlled electrical shock.

Catheter ablation destroys or isolates small areas of heart tissue responsible for abnormal electrical signals. It may be used for atrial fibrillation and several other arrhythmias.

Ablation can improve symptoms and rhythm control, but it does not guarantee that the arrhythmia will never return. Some patients still require medication or additional procedures.

Implanted Cardiac Devices

Pacemakers

A pacemaker sends electrical impulses when the heart beats too slowly or when electrical conduction is impaired.

Not every slow or irregular heartbeat requires one. The decision depends on symptoms, electrocardiographic findings, and the specific conduction problem.

Implantable cardioverter-defibrillators

An implantable cardioverter-defibrillator, or ICD, detects certain dangerous ventricular arrhythmias and delivers treatment to restore a safer rhythm.

ICDs are intended for selected people at substantial risk of sudden cardiac death. They do not prevent all arrhythmias and may occasionally deliver inappropriate shocks.

Cardiac resynchronization therapy

Cardiac resynchronization therapy coordinates the timing of the heart’s lower chambers in selected people with heart failure and electrical conduction delay.

It is not appropriate for every patient with heart failure. Eligibility depends on symptoms, ejection fraction, electrocardiographic pattern, and response to medical treatment.

Mechanical circulatory support

Advanced heart failure may require a ventricular assist device to help the heart pump blood.

These devices can serve as long-term therapy or as a bridge to transplantation. They require intensive follow-up, anti-clotting treatment, infection prevention, and specialized care.

Cardiac Rehabilitation

Cardiac rehabilitation is a medically supervised program that combines:

•individualized exercise;

•education;

•medication support;

•nutrition guidance;

•risk-factor management;

•tobacco-cessation assistance;

•psychological or stress-related support.

It may be recommended after a heart attack, coronary procedure, bypass surgery, valve surgery, or for selected people with heart failure and other cardiovascular conditions.

TheCDCandAmerican Heart Associationdescribe cardiac rehabilitation as an important part of recovery rather than an optional fitness class. It may improve function, quality of life, and long-term outcomes.

Participation may be limited by cost, transportation, work schedules, referral gaps, disability, or geographic access. Home-based and hybrid programs may be appropriate for some patients when supported by qualified teams.

Long-Term Monitoring and Self-Management

Heart disease often requires continuing management even when symptoms improve.

Follow-up may involve:

•checking blood pressure and pulse;

•reviewing symptoms and activity tolerance;

•measuring cholesterol, kidney function, or electrolytes;

•repeating electrocardiograms or imaging;

•checking implanted devices;

•reviewing medication side effects and adherence;

•monitoring for depression, anxiety, or reduced quality of life;

•reassessing treatment goals.

People with heart failure may be asked to monitor body weight, swelling, breathing, and activity tolerance. Sudden changes may reflect fluid accumulation, but the exact action plan should come from the treating team.

People taking anticoagulants or certain heart-failure medicines may require laboratory monitoring. Those with pacemakers or ICDs need scheduled device checks.

Treatment should also be reviewed when health circumstances change, including:

•pregnancy or plans for pregnancy;

•kidney or liver problems;

•new medication;

•surgery or dental procedures;

•falls or bleeding;

•major weight change;

•frailty or cognitive decline;

•changing goals of care.

A 2026 American Heart Association statement on cardiovascular polypharmacy emphasizes that supervised deprescribing may sometimes be appropriate when medicines no longer match a patient’s risks, benefits, prognosis, or priorities. Deprescribing should be clinician-led rather than attempted independently.

Practical Questions to Ask a Healthcare Team

Useful questions may include:

•What is my exact diagnosis?

•What is each medicine intended to do?

•Which side effects require a call?

•Which symptoms require emergency help?

•Do I need cardiac rehabilitation?

•Are there activity restrictions?

•How often should blood tests or imaging be repeated?

•Should I monitor blood pressure, pulse, or weight at home?

•Which over-the-counter medicines or supplements should I avoid?

•What happens if the first treatment does not control my symptoms?

•How will we know whether the treatment is working?

Written instructions can be useful, particularly after hospitalization or when several medicines have changed.

Limitations and Common Misconceptions

“A procedure cures heart disease”

A stent, bypass operation, or valve procedure may correct an important problem, but underlying risk factors and other cardiovascular disease may remain.

Long-term medication and lifestyle management may still be necessary.

“Feeling better means medication is no longer needed”

Many heart medicines prevent future complications rather than producing an obvious daily effect.

Stopping them because symptoms improve may allow blood pressure, cholesterol, clotting risk, heart failure, or arrhythmia to worsen.

“Natural supplements are safer than prescription drugs”

Supplements can interact with anticoagulants, blood-pressure medicines, rhythm drugs, and other treatment.

Products marketed for circulation, cholesterol, weight loss, or energy may contain active ingredients that affect the cardiovascular system.

“All people with heart disease should take aspirin”

Aspirin can reduce clotting but also increases bleeding risk. Its use depends on whether a person has established cardiovascular disease, a recent coronary event or procedure, and other risk factors.

“Exercise is unsafe after a cardiac diagnosis”

Many people benefit from physical activity, especially through cardiac rehabilitation. However, the safe starting level depends on diagnosis, stability, and recent procedures.

“More treatment is always better”

Some people benefit from several evidence-based therapies, while additional medication or procedures may provide little benefit or create excessive risk.

Good cardiovascular care balances longevity, symptom relief, function, safety, treatment burden, and patient preferences.

When Emergency Care Is Needed

Call the local emergency number for warning signs such as:

•new chest pressure, squeezing, heaviness, or pain;

•discomfort spreading to the arm, jaw, back, shoulder, or upper abdomen;

•sudden severe shortness of breath;

•chest symptoms with sweating, nausea, weakness, or faintness;

•sudden collapse or unresponsiveness;

•no normal breathing or only gasping;

•a severe or rapidly worsening heart-related symptom.

Do not wait to see whether suspected heart-attack symptoms resolve completely. Emergency medical teams can begin assessment and treatment during transport.

Future Outlook

Heart-disease management is moving toward earlier detection and more individualized treatment.

Current areas of development include:

•improved cardiovascular risk prediction;

•wearable and remote rhythm monitoring;

•less-invasive valve procedures;

•remote cardiac rehabilitation;

•precision treatment based on genetics or biomarkers;

•improved heart-failure medicines;

•AI-assisted imaging and clinical decision support;

•better integration of cardiovascular and kidney or metabolic care.

Technology may support monitoring and access, but it can also create false alarms, privacy concerns, unequal availability, and overreliance on automated interpretation.

The long-term value of new tools will depend on whether they improve meaningful outcomes rather than simply generate more data.

Mixed FAQ

Can heart disease be cured?

Some structural or rhythm problems can be corrected successfully. Many common cardiovascular diseases are chronic and require long-term management rather than a one-time cure.

Will everyone with coronary disease need a stent?

No. Treatment depends on symptoms, artery anatomy, disease stability, and response to medication. Some patients are managed effectively with medical therapy and lifestyle changes.

Are heart medicines usually lifelong?

Some are temporary, while others may be needed indefinitely. The duration depends on the diagnosis, procedure, risk level, and treatment response.

What is the difference between a pacemaker and an ICD?

A pacemaker mainly treats a heartbeat that is too slow or poorly coordinated. An ICD can detect and treat certain dangerous rapid rhythms.

Can heart failure improve?

Symptoms and heart function may improve with treatment in some patients. Heart failure still requires ongoing monitoring because symptoms can return or progress.

Is cardiac rehabilitation only exercise?

No. It normally combines supervised activity with education, medication support, nutrition, risk-factor management, and psychological support.

How often should heart treatment be reviewed?

The schedule depends on the condition and stability. Reviews are generally more frequent after diagnosis, hospitalization, medication changes, or procedures.